- American Association for Cancer Research
- American College of Physicians
- American Society for Transplantation and Cellular Therapy
- American Society of Clinical Oncology
- American Society of Hematology
- Center for International Blood and Marrow Transplant Research
- International Myeloma Society
- International Myeloma Working Group
- Southwest Oncology Group
- Texas Society of Clinical Oncology
Samer Al Hadidi, M.D.
- Internal Medicine - Hematology/Oncology
- Plasma Cell Disorders
- Multiple Myeloma
New Patient Appointment Accepting Virtual Visits or 214-645-4673
Biography
Samer Al Hadidi, M.D., M.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in hematology and oncology, with an emphasis on plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.
Dr. Al Hadidi earned his medical degree at the University of Jordan School of Medicine. He completed a residency in internal medicine at Hurley Medical Center/Michigan State University. He received advanced training through a hematology and oncology fellowship at Baylor College of Medicine in Houston. He also holds a master’s degree in clinical research and statistical analysis from the University of Michigan in Ann Arbor.
Certified by the American Board of Internal Medicine in internal medicine, hematology, and medical oncology, he joined the UT Southwestern faculty in 2025.
Dr. Al Hadidi is the Clinical Director of the Amyloidosis Program at UT Southwestern. He also serves as Leader of the Fellows’ Plasma Cell Disorders Clinic. He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.
A Fellow of the American College of Physicians, he is also a member of numerous professional organizations, including the American Society of Hematology, the American Society for Transplantation and Cellular Therapy, and the American Society of Clinical Oncology. Dr. Al Hadidi serves on the Hematology Specialty Board of the American Board of Internal Medicine, helping to oversee certification standards, specialty assessment, and governance policies for hematology.
Dr. Al Hadidi has delivered national and international presentations and published more than 125 peer-reviewed academic articles related to his areas of expertise.
In 2025, he received the Fellows Appreciation Award for Clinical Teaching from the University of Arkansas for Medical Sciences.
Personal Note
When he’s not at work, Dr. Al Hadidi enjoys traveling and spending time with his family.
Education & Training
- Medical School - University of Jordan Faculty of Medicine, Jordan (2005-2011)
- Residency - Hurley Medical Center - Michigan State University (2013-2016), Internal Medicine
- Graduate School - University of Michigan School of Public Health (2015-2017)
- Fellowship - Baylor College of Medicine (2018-2021), Hematology Oncology
Professional Associations & Affiliations
Honors & Awards
- Fellows Appreciation Award for Clinical Teaching 2025, University of Arkansas for Medical Sciences
- Exemplary Abstract Award 2023, International Myeloma Society Annual Meeting
- Healio Disruptive Innovators Award 2023, American Society of Clinical Oncology Annual Meeting
- Fellow of the Year 2021, Center of Cell and Gene Therapy, Baylor College of Medicine
- Fellow of the Year 2021, Gastrointestinal Oncology, Smith Clinic, Baylor College of Medicine
- Conquer Cancer Merit Award 2020, ASCO Quality Care Symposium
Books & Publications
-
Books
-
Current and Future Directions of Immunotherapies in Multiple Myeloma in American Society of Clinical Oncology Educational Book
Biltibo EMD, Surapaneni M, Al Hadidi S, Suvannasankha A, Jayani-Kosarzycki RV (2025) -
Marginal zone lymphomas (extranodal/MALT, splenic, and nodal) in Hematology: Basic Principles and Practice (8th ed.)
Al Hadidi S, Ramos CA (2023), Philadelphia, PA, Elsevier -
How to Treat High-Risk Myeloma at Diagnosis and Relapse in American Society of Clinical Oncology Educational Book
Caro J, Al Hadidi S, Usmani S, Yee AJ, Raje N, Davies FE (2021) -
Disorders of hemostasis and coagulation in Handbook of Benign Hematology
Holdener S, Al Hadidi S, Lee-Kim Y, Sosa IR, Reyes M (2020), New York, NY, Demos Medical Publishing
-
Current and Future Directions of Immunotherapies in Multiple Myeloma in American Society of Clinical Oncology Educational Book
Clinical Focus
- Plasma Cell Disorders
- Multiple Myeloma
- Light Chain Amyloidosis
- Cellular Therapies
- CAR T-Cell Therapy
- Hematopoietic Stem Cell Transplantation
Results: 1 Locations
Blood Cancers/Transplant and Cellular Therapies Clinic
at Cancer Care Outpatient Building 6202 Harry Hines Blvd., 6th FloorDallas, Texas 75235 (214) 645-4673 Directions to Blood Cancers/Transplant and Cellular Therapies Clinic at Cancer Care Outpatient Building, Dallas Parking Info for Blood Cancers/Transplant and Cellular Therapies Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-4673